Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Single-cell Alternative mRNA Splicing Patterns in Acute Myeloid Leukemia

EF 2012-13

Résumé
One of the reasons blood cancers originate is because of mutated genes. However, we know other processes related to genes are also involved in the development of blood cancer. Genes frequently recombine their sequences to change their function, this is a normal process known as 'alternative splicing'. Previous research tells us that 'alternative splicing' might be defective in blood cancer cells, and may be part of the reason why they are so dangerous. We will use a new technology to analyze the status of the 'alternative splicing' process, comparing healthy blood cells with blood cancer cells in mice. We expect that blood cancer cells will have different 'alternative splicing' than healthy cells. If we understand what the differences are in 'alternative splicing' between healthy cells and blood cancer cells, we might be able to design drugs to correct the differences in blood cancer cells in order to fight cancer. We will examine our hypothesis in a model of the blood cancer known as acute myeloid leukemia (AML), but believe our study will ultimately be relevant to other blood and non-blood cancers as well.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
269449
Name
Mcilwain David R
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Single-cell Alternative mRNA Splicing Patterns in Acute Myeloid Leukemia
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Acute Myeloid Leukemia; Alternative Splicing; Bone Marrow; Cytof Mass Cytometer; Hematopoietic Cell Differentiation; Principal Component Analysis; Rna-Seq; Single Cell Analysis
Abstract
One of the reasons blood cancers originate is because of mutated genes. However, we know other processes related to genes are also involved in the development of blood cancer. Genes frequently recombine their sequences to change their function, this is a normal process known as 'alternative splicing'. Previous research tells us that 'alternative splicing' might be defective in blood cancer cells, and may be part of the reason why they are so dangerous. We will use a new technology to analyze the status of the 'alternative splicing' process, comparing healthy blood cells with blood cancer cells in mice. We expect that blood cancer cells will have different 'alternative splicing' than healthy cells. If we understand what the differences are in 'alternative splicing' between healthy cells and blood cancer cells, we might be able to design drugs to correct the differences in blood cancer cells in order to fight cancer. We will examine our hypothesis in a model of the blood cancer known as acute myeloid leukemia (AML), but believe our study will ultimately be relevant to other blood and non-blood cancers as well.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mcilwain, David R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~